Stille

Stille Forward P/E

The Forward P/E Ratio of Stille (STIL.ST) as of Oct 24, 2026 is 28.31. In the previous year, Forward P/E Ratio was 27.09 — a change of 4.50% (higher).

Forward P/E

28.31

YoY

4.50%

Last updated:

Forward P/E Ratio of Stille is 2025 28.31 . Forward P/E Ratio of Stille was 2024 27.09 . It decreases by 4.50% higher compared to the previous year.

The Stille Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2018
78.15 SEK
Jan 1, 2019
68.93 SEK
Jan 1, 2020
190.61 SEK
Jan 1, 2021
97.97 SEK
Jan 1, 2022
57.71 SEK
Jan 1, 2023
59.18 SEK
Jan 1, 2024
27.09 SEK
Jan 1, 2025
28.31 SEK
The Stille Forward P/E history
YEARForward P/EYoY
28.31+4.50%
27.09-54.22%
59.18+2.54%
57.71-41.09%
97.97-48.61%
190.61+176.55%
68.93-11.80%
78.15-29.66%
111.11+18.29%
93.93-37.48%
150.24-81.99%
834.36—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stille Stock analysis

What does Stille do? Stille AB generates revenue by developing and selling medical equipment through two distinct business lines. The Surgery business area focuses on handcrafted, forged surgical instruments for open surgery, particularly in cardiovascular, reconstructive, and aesthetic plastic surgery. This segment produces essential tools such as scissors, forceps, artery forceps, needle holders, and clamps for medical professionals requiring precision instruments. The second revenue stream comes from the Patient Positioning area, which manufactures specialized procedure-specific tables. These devices are designed for cardiovascular surgery as well as gynecology, urology, and urodynamic examinations. By offering tailored positioning solutions for these specific medical fields, the company supports clinical procedures that require precise patient alignment. The company's operational structure includes wholly owned subsidiaries Stille Surgical Inc. and Stille Incentive AB, which support its manufacturing and distribution efforts. In 2013, the company adjusted its portfolio by selling its Sonesta business unit to ADDvise Lab Solutions publ AB, allowing it to focus on its core surgical and positioning equipment offerings. Stille is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stille stock

Forward P/E Ratio of Stille is 28.31 in 2025.

Forward P/E Ratio of Stille changed from 27.09 to 28.31, representing a 4.50% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Stille since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Stille with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Stille

All Key Metrics — Stille